In the case of IBD, the introduction of fructooligosaccharides or lactulose in healthy rats has demonstrated a combined effect of increased bacterial translocation, epithelial cell proliferation, colonic epithelial injury, and mucin production despite prebiotic consumption [200]. The gene discussed is MUC5AC; the disease is irritable bowel syndrome.